Clinical Trials
3 trialsNCT00072358 2022-05-16
Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT03557801 2019-08-14
Promotora Navigator - Culturally Appropriate Patient Navigator
Vanderbilt University Medical Center
Phase NA Completed
NCT01147601 2017-07-05
Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas
Oregon Health and Science University
Phase EARLY_PHASE1 Terminated